More about

Oregon Health And Science University

News
September 29, 2021
15 min read
Save

Battling COVID-19 vaccine misinformation: What are you telling your patients?

Battling COVID-19 vaccine misinformation: What are you telling your patients?

Weeks ago, American rapper Nicki Minaj sparked an international incident when she tweeted out to her 22.6 million followers that her cousin in Trinidad had refused the COVID-19 vaccine because his friend became impotent after receiving it.

News
September 25, 2021
2 min read
Save

NLA scientific statement navigates genetic testing for certain dyslipidemias

NLA scientific statement navigates genetic testing for certain dyslipidemias

Genetic testing can be useful for some patients with dyslipidemia, but many factors must be considered when selecting a test, according to a National Lipid Association scientific statement.

News
August 30, 2021
2 min read
Save

‘Remission’ best term to define return of normal glucose levels in type 2 diabetes

‘Remission’ best term to define return of normal glucose levels in type 2 diabetes

The term “remission” should be used to describe a person with type 2 diabetes who has achieved a disease-free status, according to a consensus report.

News
August 24, 2021
2 min read
Save

ACROSTUDY: Pegvisomant safe, effective for long-term use in acromegaly

ACROSTUDY: Pegvisomant safe, effective for long-term use in acromegaly

Real-world data from the long-term ACROSTUDY show the growth hormone receptor agonist pegvisomant is safe and effective, with a low incidence of liver enzyme elevation and no increase in tumor size for most patients with acromegaly.

News
August 10, 2021
3 min read
Save

Experts offer recommendations for management of pituitary tumors

Experts offer recommendations for management of pituitary tumors

An international panel reached consensus for pre- and postoperative endocrine testing to manage adults undergoing transsphenoidal surgery, including measurement of prolactin and insulin-like growth factor I levels for all pituitary tumors.

News
August 03, 2021
1 min read
Save

Office-based treatment may enhance methadone access for those with opioid use disorder

Office-based treatment may enhance methadone access for those with opioid use disorder

Using methadone to treat opioid use disorder in office-based settings may enhance access to this treatment without adversely affecting patient outcomes, according to results of a scoping review published in American Journal of Psychiatry.

News
July 14, 2021
2 min read
Save

Upadacitinib 15 mg sustains efficacy through 1 year in ankylosing spondylitis

Upadacitinib 15 mg sustains efficacy through 1 year in ankylosing spondylitis

Upadacitinib 15 mg demonstrates consistent, sustained efficacy in ankylosing spondylitis through year 1, according to data published in Arthritis & Rheumatology.

News
June 02, 2021
2 min read
Save

Tofacitinib displays 'significantly greater' efficacy vs. placebo in ankylosing spondylitis

Tofacitinib displays 'significantly greater' efficacy vs. placebo in ankylosing spondylitis

Tofacitinib 2 mg twice daily demonstrated “significantly greater” efficacy than placebo in adults with ankylosing spondylitis, according to researchers writing in the Annals of the Rheumatic Diseases.

News
April 06, 2021
2 min read
Save

American Association for Cancer Research announces president-elect

American Association for Cancer Research announces president-elect

Lisa M. Coussens, PhD, FAACR, has been elected president-elect of American Association for Cancer Research for the 2021-2022 term.

News
February 16, 2021
10 min read
Save

'We need to see the data': FDA's Xeljanz safety warning stirs concerns for JAK inhibitors

'We need to see the data': FDA's Xeljanz safety warning stirs concerns for JAK inhibitors

For Pfizer and its JAK inhibitor, Xeljanz, February rang in with the sound of alarm bells, as the FDA issued its third warning about the drug in 2 years.

View more